IL-15/IL-15Rα in SJS/TEN: Relevant Expression of <i>IL15</i> and <i>IL15RA</i> in Affected Skin
Teresa Bellón,
Olga González-Valle,
Elena Sendagorta,
Victoria Lerma,
Javier Martínez del Río,
Celia Martínez,
Guillermo Servera,
Carlos González-Herrada,
Lucía Cachafeiro,
José A. Lorente,
Rosario Cabañas,
Pedro Herranz,
Francisco de Abajo
Affiliations
Teresa Bellón
Drug Hypersensitivity Laboratory, Institute for Health Research Hospital Universitario La Paz (IdiPaz), 28046 Madrid, Spain
Olga González-Valle
Dermatology Department, Hospital Universitario de Getafe, 28905 Getafe, Spain
Elena Sendagorta
Dermatology Department, Hospital Universitario La Paz-Carlos III-Cantoblanco, IdiPAZ, School of Medicine, Autonomous University of Madrid, 28049 Madrid, Spain
Victoria Lerma
Clinical Pharmacology Unit, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain
Javier Martínez del Río
Drug Hypersensitivity Laboratory, Institute for Health Research Hospital Universitario La Paz (IdiPaz), 28046 Madrid, Spain
Celia Martínez
Drug Hypersensitivity Laboratory, Institute for Health Research Hospital Universitario La Paz (IdiPaz), 28046 Madrid, Spain
Guillermo Servera
Dermatology Department, Hospital Universitario La Paz-Carlos III-Cantoblanco, IdiPAZ, School of Medicine, Autonomous University of Madrid, 28049 Madrid, Spain
Carlos González-Herrada
Dermatology Department, Hospital Universitario de Getafe, 28905 Getafe, Spain
Lucía Cachafeiro
Department of Intensive Care Medicine, Hospital Universitario La Paz, 28046 Madrid, Spain
José A. Lorente
Department of Intensive Care Medicine, Hospital Universitario de Getafe, 28905 Getafe, Spain
Rosario Cabañas
Allergy Department, Hospital Universitario La Paz-Carlos III-Cantoblanco, 28046 Madrid, Spain
Pedro Herranz
Dermatology Department, Hospital Universitario La Paz-Carlos III-Cantoblanco, IdiPAZ, School of Medicine, Autonomous University of Madrid, 28049 Madrid, Spain
Francisco de Abajo
Clinical Pharmacology Unit, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain
Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a life-threatening hypersensitivity reaction to medications characterized by keratinocyte apoptosis and skin detachment. IL-15 serum levels have been associated with severity and prognosis of SJS/TEN. We have measured IL-15 concentrations in serum and blister fluid (BF) from patients with SJS/TEN by ELISA and used quantitative RT-PCR to analyze the expression of IL15 and IL15RA (encoding for IL-15 Receptor-α chain) genes in peripheral blood and BF cells, including isolated monocytes, and in affected skin. A positive correlation was found between IL-15 serum levels and a percent of detached skin. BF concentrations were higher, but no correlation was found. Higher IL15 and IL15RA gene expression levels were found in skin-infiltrating blister fluid cells compared to peripheral mononuclear cells. Moreover, IL15RA transcripts were barely detected in healthy skin, being the highest expression levels found in samples from two SJS/TEN patients who did not survive. The cutaneous expression of IL-15Rα in SJS/TEN may provide an explanation to the tissue-specific immune cytotoxic response in this clinical entity, and the results suggest that the effects of IL-15 in SJS/TEN patients may be dependent on the expression of its private receptor IL-15Rα in affected skin.